Evidence map›Paper›PMID 25260027›Full record

ArticlePloS one2014

Etanercept attenuates myocardial ischemia/reperfusion injury by decreasing inflammation and oxidative stress.

Mei Yang, Jianchang Chen, Jing Zhao, Mei Meng

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Mei YangDepartment of Critical Care Medicine, the Third Hospital of Jinan, Jinan, People's Republic of China.
Jianchang ChenDepartment of Emergency, Shandong Provincial Hospital, Jinan, People's Republic of China.
Jing ZhaoDepartment of Cardiology, Qilu Hospital of Shandong University, Jinan, People's Republic of China.
Mei MengDepartment of Critical Care Medicine, Shandong Provincial Hospital, Jinan, People's Republic of China.
Shandong Provincial Hospital · CNFourth People’s Hospital of Jinan · CNQilu Hospital of Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The protective role of etanercept in myocardial ischemia/reperfusion is not well understood. The aim of this study was to investigate whether etanercept modulates neutrophil accumulation, TNF-α induction and oxidative stress in an ischemia/reperfusion injured rat heart model. Rats were randomly exposed to sham operation, myocardial ischemia/reperfusion (MI/R) alone, MI/R+ etanercept. The results demonstrated that compared to MI/R, etanercept reduced myocardial infarction area, myocardial myeloperoxidase (MPO) levels, serum creatinine kinase (CK) and lactate dehydrogenase (LDH) levels, and both serum and myocardial TNF-α production. Etanercept also markedly enhanced the activities of antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase (GSH-PX), and reduced the level of malondialdehyde (MDA) in MI/R rats. In summary, our data suggested that etanercept has protective effects against MI/R injury in rats, which may be attributed to attenuating inflammation and oxidative stress.

Indexed as

AnimalsApoptosisCreatine Kinase, MB FormDisease Models, AnimalEtanerceptGene Expression RegulationGlutathione PeroxidaseImmunoglobulin GInflammationLactate DehydrogenasesMaleMalondialdehydeMyocardial InfarctionMyocardial Reperfusion InjuryMyocytes, CardiacNeutrophil InfiltrationCreatine Kinase, MB FormEtanerceptGlutathione PeroxidaseImmunoglobulin GLactate DehydrogenasesMalondialdehydeReceptors, Tumor Necrosis FactorSuperoxide DismutaseToll-Like Receptor 4Troponin ITumor Necrosis Factor-alpha

Identifiers

PMID25260027
PMCPMC4178063
OpenAlexW2021582794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.